This clinical trial is focused on patients with Coronary Artery Disease, a condition where the blood vessels supplying the heart become narrowed or blocked. The study is investigating the effects of different antiplatelet medications, which help prevent blood clots. The medications being studied include Acetylsalicylic Acid (commonly known as aspirin), Clopidogrel, Ticagrelor (also known by the code name AZD6140), and Prasugrel. These medications are used to reduce the risk of heart attacks and other heart-related issues by preventing platelets in the blood from sticking together.
The purpose of the study is to evaluate the outcomes of using a reduced antiplatelet therapy after the implantation of an Angiolite stent, a small tube placed in the coronary arteries to keep them open. The study will compare the effects of a standard dual antiplatelet therapy (using two medications) with an abbreviated, or shortened, therapy. Participants will be randomly assigned to receive either the standard or the abbreviated therapy. The study will last for up to 12 months, during which the rate of heart-related complications and bleeding events will be monitored.
Participants will take the medications orally, meaning they will swallow them in pill form. The study aims to determine if the abbreviated therapy is as effective as the standard therapy in preventing heart-related issues while also reducing the risk of bleeding. This research is important for understanding how to best manage treatment for patients with coronary artery disease who have received a stent.



Belgium
France
Spain